H.R. 3164 · 119th Congress · Health

Ensuring Community Access to Pharmacist Services Act

Provides permanent Medicare coverage for pharmacist testing and treatment services. AI-read

In committee544 words Introduced May 1, 2025 · Latest action May 21, 2026

How far it has goneStage 2 of 6
  1. IntroducedMay 1, 2025 Done
  2. CommitteeReferred to 2 committees Current stage
  3. House floorNot yet Not reached yet
  4. Senate floorNot yet Not reached yet
  5. Chambers agreeNot yet Not reached yet
  6. PresidentNot yet Not reached yet

What it does

This bill provides for permanent coverage under Medicare of certain pharmacist services.

Specifically, the bill provides for permanent coverage of testing and treatment services provided by pharmacists relating to (1) COVID-19, influenza, respiratory syncytial virus (RSV), and streptococcal pharyngitis (strep throat); and (2) other public health needs in relation to a declared public health emergency. (Similar authorities were temporarily granted during the COVID-19 public health emergency.) Such services must be provided in accordance with the applicable state laws governing pharmacists' scope of practice.

Congressional Research Service · summary of “Introduced in House” version · May 1, 2025

Who lobbies on it

27 organizations, more than 99% of House bills · 160 filings · Q2 2025–Q3 2026

These 27 organizations’ PACs gave $3.4M to 137 of the 145 members sponsoring or cosponsoring H.R. 3164 in the 2025–26 election cycle.

See who got it, from which PACs, and how they compare to the rest of the House → Pro

One square per quarter since introduction, oldest left. Filled = named it that quarter.

  1. American Medical Association 6 of 6 quarters
    “Issues related to Physician Fee Schedule and physician payment reform; H.R. 879, Medicare Patient Access and Practice Stabilization Act; H.R. 3164/S. 2426, Equitable Community Access to Pharmacist Services Act; H.R. 8163/S. 5180, Provider Reimbursement Stability Act; Issues related to Provider Reimbursement Stability…”

    $17.6M lobbying spend in 2026 to date, all issuesQ3 2026 filing

  2. Pharmaceutical Care Management Association 6 of 6 quarters
    “S.1637/H.R 7871; Medicaid VBPs for Patients Act S. 2426/H.R. 3164; Ensuring Community Access to Pharmacist Services Act S. 2617/H.R. 1244; Reducing Drug Prices for Seniors Act S. 882; Patients Before Middlemen Act S. 927; Protecting Pharmacies in Medicaid Act S. 1041; Affordable Prescriptions for Patients Act S. 2800…”

    $9.5M lobbying spend in 2026 to date, all issuesQ3 2026 filing

  3. Cvs Health (and Subsidiaries) 6 of 6 quarters
    “Issues related to retail pharmacy, drug pricing, and women's health. H.R. 3164 - The Main Street Pharmacy Access Act S. 2426 - The Equitable Community Access to Pharmacist Services Act H.R. 5031, The Preserving Patient Access to Long-Term Care Pharmacies Act”

    $8.9M lobbying spend in 2026 to date, all issuesQ3 2026 filing

24 more organizations, every filingPROUpgrade

Organizations that named H.R. 3164 in a quarterly lobbying report. Covers organizations with a PAC on file; reports from organizations without one aren’t loaded yet. Spend is the organization’s total across all issues: reports don’t split spending by bill. “Gave to” means the organization’s PAC gave to the member’s campaign in the 2025–26 cycle, net of refunds; it doesn’t mean the money was about this bill. Organizations may lobby for, against, or to change a bill; filings don’t say which. Source: Senate lobbying disclosures (LD-2) from lda.gov; PAC gifts from FEC filings; quotes are word for word from the “specific lobbying issues” field; where a filing lists many bills, the quote starts where it names this one.

Actions

4 actions · newest first
  1. May 21, 2026Ordered to be Reported in the Nature of a Substitute by Voice Vote.
  2. May 21, 2026Committee Consideration and Mark-up Session Held
  3. May 1, 2025Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
  4. May 1, 2025Introduced in House

What members said about it

  • Statement · Press release · May 21, 2026 · Smith R-NE

    WHAT THEY ARE SAYING: Smith's Main Street Pharmacy Access Act Clears Ways and Means Committee

    Today, Congressman Adrian Smith’s (NE-03) Main Street Pharmacy Access Act, which would empower local pharmacists to play a more active role in community health by allowing Medicare Part B reimbursement for testing and treating common…

    “This bill is a commonsense, creative solution to address the barriers to health care access that rural and underserved communities suffer every day. I want to thank Representative Adrian Smith for championing this bill for the benefit of Nebraskans and communities across this country so that seniors will gain access to…”